Hematology and Medical Oncology Services
At the OHSU Knight Cancer Institute, our Hematology and Medical Oncology team treats and studies blood cancer and other blood diseases as well as solid tumors. As part of Oregon’s only academic medical center, our experts not only diagnose and treat cancer but also are in the forefront of cancer research to discover new treatments. They are also educating the next generation of cancer researchers and doctors.
Organized into multidisciplinary care teams focused on specific types of cancer, our scientists and specialists from medicine, surgery, radiation therapy, nursing, social work and other areas work together to provide you with individualized diagnosis, treatment, rehabilitation and follow-up care in areas including:
- Breast cancer
- Bladder cancer
- Colon cancer
- Germ cell tumors
- Head and neck cancer
- Kidney cancer
- Lung cancer
- Prostate cancer
- Other solid tumor malignancies
As part of the OHSU Knight Cancer Institute, the OHSU Center for Hematologic Malignancies treats blood cancers including leukemia, lymphoma, multiple myeloma and myleodysplasia. We offer a wide range of treatment options, such as bone marrow transplants and participation in clinical trials. Our areas of emphasis include stem cell transplantation and chronic myelogenous leukemia.
We also treat blood disorders that are not cancer, such as coagulation disorders, hemophilia, sickle cell disease and bone marrow failure syndromes.
In addition to our multidisplinary teams, our team is led by Dr. Thomas DeLoughery who also oversees the Solid Tumor Programs. He is supported by Dr. Richard Maziarz for Bone Marrow and Stem Cell Transplant, Dr. Grover Bagby for Hematologic Malignancies and Dr. Jacqueline Vuky for Community Hematology Oncology.
We have clinics in Gresham, Tualatin, Northwest Portland, Beaverton and East Portland. You can see a doctor in your neighborhood at a clinic near you. At these locations, we provide general medical oncology services including treatment planning, second opinions, follow-up services, support from social work and nursing staff, chemotherapy and infusion treatments and access to clinical trials.